Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Atezolizumab
Related studies linked through entity extraction aliases.
NCT Neuro Master Match - N²M² (NOA-20)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab Immunotherapy in Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PDL-1 Targeting in Resectable Oesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE1
Immunotherapy as Second-line in Patient With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2